Enzyme-potentiated desensitization in otolaryngic allergy.
This is a preliminary report of a new method of treating otolaryngic allergy with enzyme-potentiated desensitization (EPD). The nature of EPD and its use in otolaryngology are described. Thirty-six patients have been treated and followed in a private medical practice since February 1997. This article reviews the clinical features of EPD and provides six cases as examples; the clinical features described include allergic rhinitis, serous otitis media, asthma, dermatitis, fixed food allergy, and Ménière's disease. EPD is an effective technique for the treatment of otolaryngic allergy and offers advantages over conventional techniques.
Pulec
Jack L
JL
Pulec Ear Clinic, 1245 Wilshire Blvd., Suite 503, Los Angeles, CA 90017, USA. pulecear@aol.com
D000293:Adolescent; D000328:Adult; D000941:Antigens / Q000008:administration & dosage*; D003888:Desensitization, Immunologic / Q000379:methods*; D005260:Female; D005966:Glucuronidase / Q000008:administration & dosage*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*
D000941:Antigens; D005966:Glucuronidase